Immunoassays are used for the specific measurement of type II collagen
, a major.cartilage protein, which is lost in osteoarthritic joints. P
oor immunogenicity and species dependent immune response to type II co
llagen make it difficult to obtain specific antibodies required for im
munoassay development. In addition, type II collagen antibodies exhibi
t reactivity to structurally dissimilar antigens such as actin, myoglo
bin, thyroglobulin and ssDNA, complicating the isolation of specific a
ntibodies. It is therefore necessary to characterize the antibody reac
tivity against both noncollagenous antigens and different collagen typ
es. In this study, immune response to type II collagen was improved by
conjugation to carrier proteins, KLH and BSA. Hybridomas were generat
ed by fusions of lymphocytes derived from lymph nodes or spleens with
X63-653-Ag8 myeloma cells. Compared to spleens, the utilization of lym
ph nodes as a source of lymphocytes resulted in a 23% higher number of
hybridomas secreting type II collagen antibodies. Hybridomas secretin
g polyreactive antibodies were identified based on their reactivity to
thyroglobulin and eliminated. Extensive testing of the remaining mono
clonal antibodies with other structurally dissimilar antigens and vari
ous types of collagen for reactivity, allowed us to isolate specific m
onoclonal antibodies to type II collagen. We emphasize the importance
of characterization of the reactivity of type II collagen monoclonal a
ntibodies before employing them for immunoassays.